AKT1 and urinary bladder cancer: However, a previous study on bladder cancer detected a mutation in the PH domain, namely (E49K), which was demonstrated as an enhancer activation mutation that transforms activity in NIH3T3 cells, proposing cooperative enhancement of the AKT1 when it tandemly contains E17K hotspot mutation [39].